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Antitermination (At) is a ubiquitous principle in the regulation of bacterial transcription to suppress 
termination signals. in phage λ antiterminator protein Q controls the expression of the phage’s late 
genes with loading of λQ onto the transcription elongation complex halted at a σ-dependent pause 
requiring a specific DNA element. The molecular basis of λQ-dependent At and its dependence on 
n-utilization substance (nus) A is so far only poorly understood. Here we used solution-state nuclear 
magnetic resonance spectroscopy to show that the solution structure of λQ is in agreement with the 
crystal structure of an N-terminally truncated variant and that the 60 residues at the N-terminus are 
unstructured. We also provide evidence that multidomain protein nusA interacts directly with λQ via its 
N-terminal domain (NTD) and the acidic repeat (AR) 2 domain, with the λQ:NusA-AR2 interaction being 
able to release NusA autoinhibition. The binding sites for NusA-NTD and NusA-AR2 on λQ overlap 
and the interactions are mutually exclusive with similar affinities, suggesting distinct roles during 
λQ-dependent At, e.g. the λQ:nusA-ntD interaction might position nusA-ntD in a way to suppress 
termination, making nusA-ntD repositioning a general scheme in At mechanisms.
Transcription of all cellular genomes is mediated by evolutionary related multisubunit RNA polymerases 
(RNAPs)1. RNA synthesis is a discontinuous process that underlies tight regulation by various transcription fac-
tors that bind to RNAP, affecting its processivity. In Gram-negative bacteria the core RNAP consists of five subu-
nits (2 x α, β, β’, ω). The flap region of the β subunit forms the outer wall of the RNA exit channel with the β flap tip 
helix (βFTH) at the top of this region being able to regulate the width of the channel, making it a key regulatory 
element2–8.
Antitermination (AT) is a ubiquitous mechanism to suppress termination signals and is widely used in bacte-
ria. AT has first been described for bacteriophage λ where it controls the expression of early and late genes, being 
thus essential for the life cycle of the phage9. Phage λ uses two AT mechanisms which involve either antitermina-
tor protein N or antiterminator protein Q. In λN-dependent AT the intrinsically disordered protein N is recruited 
to elongating RNAP by an AT signal in the nascent RNA and forms a complex with RNAP and the Escherichia coli 
(E. coli) host factors N-utilization substances (Nus) A, B, E, and G6,7. In this transcription AT complex (TAC) λN 
repositions NusA and remodels the βFTH, enabling the TAC to read through termination signals by preventing 
the formation of pause/terminator hairpins6,7.
In λQ-dependent AT protein λQ requires a λQ binding element (QBE) on the DNA for recruitment and is 
loaded onto RNAP halted at an adjacent sigma-dependent promoter-proximal pause site10,11. Recent cryo elec-
tron microscopy (EM) studies of the AT mechanism of protein Q from phage 21, Q21, revealed that two Q21 
proteins engage with RNAP in a Q21-TAC, one of which forms a torus at the RNA exit channel, narrowing it to 
prevent the formation of pause/terminator hairpins12,13. Currently, over 15,000 lambdoid bacteriophage Q pro-
teins have been identified, which can be grouped into three families (Q21 family: Pfam PF06530, λQ family: Pfam 
PF03589, and Q82 family: Pfam PF06323), and crystal structures of Q21 and an N-terminally truncated variant 
of λQ are available12–14. Although all Q proteins are encoded by genes located at equivalent positions in bacteri-
ophage genomes and perform the same regulatory function they show neither significant amino acid sequence 
nor significant 3D structural similarity to each other, suggesting that the mechanism by which they mediate AT 
may be different.
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AT does not only play a role in the life cycle of bacteriophages but is necessary for the expression of certain 
bacterial genes15,16. In ribosomal AT, for example, RNAP pauses at an AT signal and a TAC is formed that contains 
Nus factors A, B, E, and G as well as further components such as ribosomal protein S4 and inositol monophos-
phatase SuhB17–20. If this TAC is only responsible for AT or also involved in posttranscriptional activities, e.g. 
RNA maturation, is yet unclear.
Thus, Nus factors are key players in transcription regulation with NusG being a representative of the only 
class of transcription factors that is conserved in all three kingdoms of life21. E. coli NusG consists of two flex-
ibly connected domains, an N-terminal and a C-terminal domain (NTD, CTD), respectively (Supplementary 
Fig. 1a)22. NusG-NTD has a mixed α/β topology and binds to the β’ clamp helices of RNAP, increasing its pro-
cessivity, whereas NusG-CTD forms a five-stranded β-barrel that can interact with different binding partners 
(reviewed in23). For example, NusG-CTD is able to bind termination factor Rho, resulting in stimulation of 
Rho-dependent termination24–26, or to ribosomal protein S10 so that NusG serves as physical linker between 
RNAP and the ribosome to couple transcription and translation24. S10 consists of one domain with mixed α/β 
topology and is a moonlighting protein, i.e. it is identical to transcription factor NusE, if it is not part of the 
ribosome (Supplementary Fig. 1b). In this case NusE forms a heterodimer with NusB (Supplementary Fig. 1b), 
an α-helical, one-domain protein. During λN-dependent AT the NusE:NusB complex recognizes specifically a 
boxA element on the RNA with both NusE and NusB making contacts to the RNA27,28. NusE is the active com-
ponent in processive AT whereas NusB supports loading of NusE to the transcription machinery27. NusG-CTD 
can interact with NusE and thus anchors the NusE:NusB:boxA complex to the RNAP6,7,24. NusG-mediated teth-
ering of NusE:NusB:boxA to the RNAP might also be important for ribosomal AT17,18. The multidomain protein 
NusA (Supplementary Fig. 1c) is highly conserved in bacteria and regulates pausing and termination2,29, AT 
processes30–32, and RNA folding33. NusA-NTD binds to the βFTH2,6,7 and to the CTD of one of the RNAP α 
subunits (αCTD)2, whereas the following three domains (S1, K homology (KH)1, KH2) form the compact RNA 
binding motif SKK34. In E. coli and other γ-proteobacteria NusA has two acidic repeat (AR) domains, AR1 and 
AR2, at its C-terminus35. NusA-AR1 interacts with λN36–38, whereas NusA-AR2 serves as recruitment platform 
for various transcription factors such as the αCTD39, NusG-NTD40, and SuhB17,18. NusA is regulated via autoinhi-
bition as NusA-AR2 binds to the KH1 domain, preventing RNA binding by NusA-SKK39,41,42. This autoinhibition 
may be released by RNAP αCTD to activate RNA binding by NusA39, by SuhB during ribosomal AT17,18 or by 
NusG-NTD, a process that might be play a role during NusG recruitment, in resynchronization of transcrip-
tion:translation coupling or in modulation of termination efficiency40.
Nus factors are involved in various AT mechanisms. It has been demonstrated that NusA is able to stimulate 
Q-dependent AT in phage 8243 and it has been suggested that NusA promotes recruitment of Q in phage λ32. Here, 
we used solution-state nuclear magnetic resonance (NMR) spectroscopy to provide conclusive evidence that of 
all Nus factors only NusA interacts directly with λQ, establishing interactions via its NTD and AR2 domain. As 
NusA-NTD and λQ share binding sites on RNAP, the NusA-NTD:λQ interaction might be responsible for reposi-
tioning of NusA, stimulating λQ-mediated AT. We show that binding of λQ to NusA-AR2 releases autoinhibition 
of NusA, implying that NusA-AR2 is not only a versatile interaction platform for various transcription partners, 
but suggesting that NusA may be regarded as regulatory subunit of RNAP that substitutes the sigma factor.
Results
the solution structure of λQ. The 60 residues at the N-terminus of λQ are highly polar and are suggested 
to be disordered as, until now, only the crystal structure of a λQ variant lacking 38 residues at the N-terminus 
could be determined and even the electron density of this deletion variant was only interpretable starting at 
residue 62 (Fig. 1a)14. As the N-terminus, however, might have a functional role we used solution-state NMR 
spectroscopy to study the full length protein. The [1H,15N]-band-selective excitation short-transient transverse 
relaxation optimized spectroscopy (BEST-TROSY) spectrum of 15N-labeled λQ showed good signal disper-
sion (Fig. 1b) and perfectly superimposes with the spectrum of a λQ deletion variant lacking 36 residues at the 
N-terminus (λQΔ36). Additional signals in the spectrum of the full length protein are all located between 7.5 and 
8.5 ppm in the proton dimension, typical for random coil structures, suggesting that the N-terminus is indeed 
disordered in solution (Fig. 1b). Using λQΔ36 we assigned 75.4% of the amide backbone and 78.4% of the Cα 
backbone signals (Fig. 1a). Unassigned residues are especially located at the N-terminus, at the C-terminal end 
of helix α3 (aa 108–120) and in the center of helix α6 (aa 189–198). The chemical shift index (CSI) of Cα and CO 
atoms is in perfect agreement with the crystal structure (Fig. 1c), demonstrating that the three-dimensional (3D) 
structures in solution and in the crystal are identical. Analytical gel filtration showed that protein solutions of λQ 
and λQΔ36 were homogeneous, giving molecular weights of 30 kDa and 17 kDa for λQ and λQΔ36, respectively 
(theoretical molecular mass: 23 kDa and 16 kDa), indicating that both proteins exist as monomers in solution 
(Supplementary Fig. 2a). Next, we determined the 15N relaxation behavior of λQΔ36 by NMR spectroscopy at 
16.8 T magnetic field strength (Supplementary Fig. S2b) to characterize the overall tumbling of the protein. We 
obtained averaged 15N relaxation rates of 0.84 ± 0.06 s−1 and 19.5 ± 0.6 s−1 for R1 and R2, respectively. Assuming 
isotropic tumbling, these rates correspond to a rotation correlation time τc of 14 ± 1 ns, which suggests a molec-
ular weight of ~23 kDa. This result supports the conclusion that the protein is a monomer in solution. The fact 
that the experimentally determined molecular weights of λQ and λQΔ36 are slightly larger than the theoretical 
values for the monomeric proteins might be attributed to the facts that (i) both have an unstructured N-terminus 
(60 and 30 amino acids, respectively) and (ii) both have an elongated shape, i.e. both do not behave like perfectly 
globular proteins.
λQ directly interacts with nusA. Nus factors are involved in both λN-dependent and ribosomal AT. 
They are part of huge nucleoprotein complexes that modify RNAP into a termination-resistant state, so-called 
TACs6,7,17,18,20. Efficient λQ-dependent AT requires at least NusA44, which is thought to stabilize binding of 
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λQ to the TEC32. Thus, we used solution-state NMR spectroscopy to test if λQ directly interacts with any of 
the Nus factors. We titrated 15N-labeled λQ with individual Nus factors and recorded one-dimensional (1D) 
[1H,15N]-heteronuclear single quantum coherence (HSQC) and two-dimensional (2D) [1H,15N]-BEST-TROSY 
spectra (Supplementary Fig. 3). For NusE we employed a protein variant which lacks the ribosome binding loop 
(NusEΔ), and which is in complex with NusB to increase solubility27. Only the presence of NusA (54.9 kDa) led 
to a significant change in the spectra of 15N-λQ (Supplementary Fig. 3), namely the signal intensity of 15N-λQ 
was significantly decreased upon addition of NusA (Supplementary Fig. 3a). Slower tumbling leads to increased 
transverse relaxation rates, which results in line broadening and thus ultimately in a decrease of signal intensity of 
15N-λQ signals. Consequently, the loss of 15N-λQ signal intensity suggests a direct λQ:NusA interaction.
λQ binds to nusA-ntD. In order to identify the region of NusA that binds to λQ we carried out 
[1H,15N]-HSQC-based titrations of λQ and the individual domains of NusA with 1D and 2D spectra being 
recorded after each titration step. Titration of 15N-λQ with NusA-NTD led to a significant change of the 15N-λQ 
spectrum (Fig. 2a and Supplementary Fig. 4a), indicating complex formation. Likewise 15N-NusA-NTD signals 
were substantially affected in the presence of λQ (Fig. 2b and Supplementary Fig. 4b). In both titrations the sig-
nal intensity of the labeled protein was decreased non-uniformly upon addition of the binding partner whereas 
chemical shift perturbations were only small, suggesting intermediate or slow chemical exchange on the NMR 
Figure 1. Structure of λQΔ36. (a) Ribbon representation of the crystal structure of a λQ truncation variant 
lacking 38 residues at the N-terminus, electron density was only interpretable starting at residue 62 (PDB ID: 
4MO1; gray). Termini and secondary structure elements are labeled. Unassigned amide backbone signals are 
shown in black, the Zn2+ is highlighted as cyan sphere. The PyMOL Molecular Graphics System (Version 1.7, 
Schrödinger, LLC.; https://pymol.org) was used for visualization. (b) Overlay of [1H,15N]-BEST-TROSY spectra 
of 15N-λQ (red) and 15N-λQΔ36 (black). (c) Chemical shift index (CSI) for Cα and CO of λQΔ36 vs. secondary 
structure of the crystal structure (PDB ID: 4MO1). The missing residues due to non-interpretable electron 
density are indicated in red, the loop region is shown in cyan.
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time scale. Thus, in both titrations the change of signal intensity was analysed quantitatively by calculating the 
relative signal intensity of the 15N-labeled protein in the presence of one equivalent of the non-labeled binding 
partner (for details see Material and Methods). In brief, we defined the relative intensity as ratio of the normalized 
remaining signal intensity of the 15N-labeled protein in the presence of the binding partner to the normalized 
signal intensity of the free labeled protein. The relative intensity was plotted against the corresponding amino acid 
position (Fig. 2a,b) and thresholds at 1.5 σ and 1.0 σ of the mean relative signal intensity were used to identify 
strongly and moderately affected residues, respectively, which were then mapped onto the 3D structures of λQ 
and NusA-NTD (Fig. 2c). λQ residues affected by NusA-NTD binding form two continuous patches. The first 
patch involves residues located in α3 and α5, the second patch contains residues at C- and N-terminal parts of 
Figure 2. NusA interacts with λQ via its NTD. (a) (top) Section of [1H,15N]-BEST-TROSY spectra of the 
titration of 250 µM 15N-λQ with NusA-NTD (molar ratios: 1:0, black; 1:1, cyan; 1:2 red). Selected signals are 
labeled. (bottom) Relative intensity of 15N-λQ signals in the presence of one equivalent NusA-NTD. Orange 
and red lines indicate thresholds for moderately (1.0 σ of average relative signal intensity) and strongly (1.5 σ 
of average relative signal intensity) affected signals, respectively. The dashed line represents the mean relative 
intensity, error bars are given as black vertical lines. (b) (top) Section of [1H,15N]-HSQC spectra of the titration 
of 175 µM 15N-NusA-NTD with λQ (molar ratios: 1:0, black; 1:1, cyan; 1:2 red). Selected signals are labeled. 
(bottom) Relative intensity of 15N-NusA-NTD signals in the presence of one equivalent λQ with error bars. 
Thresholds as in (a). (c) Model of the λQ:NusA-NTD complex. The model was generated with the HADDOCK 
2.2 server (https://haddock.science.uu.nl/services/HADDOCK2.2/) using affected residues as determined 
via NMR spectroscopy as restraints (see Supplementary Table 1). The model with the lowest HADDOCK and 
Z-score is depicted. λQ (PDB ID: 4MO1, lightblue) and NusA-NTD (PDB ID: 2KWP, gray) are shown in ribbon 
representation. Affected residues are colored (moderately affected residues, orange; strongly affected residues, 
red). Termini and secondary structure elements are labeled. Panels show the surface representations of λQ 
(left) and NusA-NTD (right) colored as in the complex. The PyMOL Molecular Graphics System (Version 1.7, 
Schrödinger, LLC.; https://pymol.org) was used for visualization. (d) αCTD detaches NusA-NTD from 15N-λQ. 
Sections of [1H,15N]-BEST-TROSY spectra are shown. Molar ratios: 15N-λQ:NusA-NTD: αCTD = 1:0:0, black; 
=1:2:0, cyan; 1:2:2, orange; 1:2:4, red. Initial concentration of 15N-λQ: 250 µM. Selected signals are labeled, 
arrows indicate chemical shift changes upon addition of NusA-NTD (cyan) and αCTD (red). (e) λQ removes 
NusA-NTD from 15N-αCTD. Sections of [1H,15N]-HSQC spectra are shown. Molar ratios: 15N-αCTD:NusA-
NTD:λQ = 1:0:0; black; =1:2:0; cyan; 1:2:2; orange; 1:2:4, purple; 1:2:6, yellow; 1:2:10, red. Initial concentration 
of 15N-αCTD: 250 µM. Selected signals are labeled, arrows indicate chemical shift changes upon addition of 
NusA-NTD (cyan) and λQ (red).
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the Zn-binding motif (Fig. 2c, left inset). NusA-NTD residues affected by binding of λQ are primarily located in 
the acidic head region and the upper part of the body region at the convex side of NusA-NTD. Due to insufficient 
long-term stability we did not record intermolecular nuclear Overhauser effect (NOE) interactions. Thus a dock-
ing model was generated based on the affected residues in both proteins and without allowing conformational 
rearrangements (Supplementary Fig. 4c-e). In the lowest energy model (Fig. 2c) the acidic head of NusA-NTD 
contacts the Zn-finger of λQ and the upper part of the NusA-NTD body interacts with the second patch of λQ, 
giving an overall interface area of 1050 Å².
We also checked if the unstructured N-terminus of λQ is involved in NusA-NTD binding by titrat-
ing 15N-NusA-NTD with λQΔ36 and recorded a 2D [1H,15N]-HSQC spectrum after each titration step 
(Supplementary Fig. 5a). Like in the titration with full length λQ the intensity of 15N-NusA-NTD signals was 
significantly decreased in the presence of λQΔ36, and the relative signal intensity in the equimolar titration step 
was plotted against the amino acid position of NusA-NTD (Supplementary Fig. 5b). Mapping of the affected 
residues onto the NusA-NTD structure (Supplementary Fig. 5c) resulted in the same binding site as identified 
in the titration with full length λQ, indicating that the N-terminus of λQ does not influence the interaction with 
NusA-NTD.
λQ and RnApαctD share binding sites on nusA-ntD. NusA-NTD contacts two regions of RNAP, 
the βFTH and the αCTD2. The λQ binding site is located on the convex side of NusA-NTD, overlapping with the 
binding site for RNAP αCTD2, thus suggesting that binding of λQ and αCTD might be competitive. To test if 
the interactions of αCTD and λQ with NusA-NTD are mutual exclusive, we performed NMR-based competition 
experiments with [1H,15N]-HSQC spectra being recorded after each titration step. First, NusA-NTD was added in 
a two-fold molar excess to 15N-Q, resulting in signal changes typical for 15N-λQ:NusA-NTD complex formation 
(Fig. 2d and Supplementary Fig. 6a; see also Fig. 2a). Subsequent titration with αCTD reversed the signal changes 
(both chemical shift changes and loss of signal intensity), demonstrating that αCTD binds to NusA-NTD, detach-
ing it from λQ. To confirm this finding we carried out a reverse experiment where NusA-NTD was added to 
15N-αCTD in a 1:2 molar ratio, leading to chemical shift perturbations that indicate complex formation. Addition 
of λQ reversed those changes, indicating that λQ removes NusA-NTD from αCTD by complexing it (Fig. 2e and 
Supplementary Fig. 6b). These results imply that the λQ:NusA-NTD and αCTD:NusA-NTD interactions are 
mutually exclusive and have similar affinities, which, in turn, suggests that both interactions are physiologically 
relevant. We excluded a direct αCTD:λQ interaction as the titration of 15N-λQ with αCTD did not alter the spec-
tra of 15N-λQ (Supplementary Fig. 6c).
λQ does not interact with NusA-SKK and NusA-AR1. Having identified NusA-NTD as interaction 
partner of λQ we tested next if also NusA-SKK binds to it. We titrated 15N-labeled λQ with NusA-SKK and vice 
versa and recorded 1D- and 2D-[1H,15N] correlation spectra after each titration step (Supplementary Fig. 7a,b). 
Even in the presence of a twofold molar excess of the unlabeled binding partner no significant changes were 
observable in the spectra of the labeled protein, excluding a direct NusA-SKK:λQ interaction. Using the same 
approach we asked if λQ binds to NusA-AR1, which contacts λN in λN-dependent AT36–38, but again, no direct 
interaction could be detected (Supplementary Fig. 7c,d).
λQ binds to NusA-AR2. Finally, we tested if λQ interacts with NusA-AR2. Upon addition of NusA-AR2 
to 15N-λQ the 1D and 2D spectra of 15N-λQ changed significantly (Fig. 3a and Supplementary Fig. 8a). As in 
the titration of 15N-λQ with NusA-NTD, the intensity of 15N-λQ signals decreased non-uniformly whereas only 
slight chemical shift perturbation were observable. Thus, we analyzed the change of signal intensity quantitatively. 
The relative intensity of 15N-λQ signals in the presence of two equivalents NusA-AR2 was plotted against the 
amino acid sequence of λQ and affected residues were identified by using thresholds at 1.5 and 1.0 σ of the mean 
relative intensity (Fig. 3a). In contrast, the titration of 15N-NusA-AR2 with λQ resulted in significant chemical 
shift perturbations and normalized chemical shift changes (Δδnorm) were plotted against the amino acid sequence 
of NusA-AR2 (Fig. 3b and Supplementary Fig. 8b). To visualize binding surfaces affected residues were mapped 
on the 3D structures of λQ and NusA-AR2 (Fig. 3c). λQ residues affected by NusA-AR2 binding are located 
opposite the Zn binding motif and the flexible arm, and strongly affected residues can be found predominantly 
in helices α3 and α5.
The λQ binding site of NusA-AR2 is located at the C-terminal part of the domain and comprises helix α5*, 
with W490 and F491 being strongly affected. These two residues are known to be responsible for the specific rec-
ognition of other transcription regulators such as αCTD39, NusG-NTD40, or SuhB17,18. As for the λQ:NusA-NTD 
complex, we did not record intermolecular NOE interactions due to insufficient long-term stability of λQ. 
Based on the identified binding surfaces a docking model of the λQ:NusA-AR2 complex was generated with-
out allowing conformational rearrangements (Supplementary Fig. 8c-e). In the lowest energy model (Fig. 3c) 
helix α5* of NusA-AR2 packs against helices α3 and α5 of λQ so that W490 and F491 are central parts of the 
interface, which comprises a total area of 1230 Å². Finally, we determined the KD for the λQ:NusA-AR2 com-
plex by fluorescence anisotropy measurements using NusA-AR2D443C, a NusA-AR2 variant where D443, located 
opposite the λQ binding site, is substituted by a Cys18. NusA-AR2D443C was labeled site-specifically with fluo-
rescein5-maleimide and titrated with λQ, giving a KD of 268 ± 17 µM (Supplementary Fig. 8f). Repeating the 
HSQC-based titration of 15N-NusA-NTD with λQΔ36 resulted in the same binding surface as determined for 
full length λQ (Supplementary Fig. 8g-i), suggesting that the unstructured N-terminus of λQ is not involved in 
NusA-AR2 binding. This finding was corroborated by fluorescence anisotropy measurements as the affinity of the 
NusA-AR2D443C:λQΔ36 interactions was determined to be 271 ± 27 µM (Supplementary Fig. 8j).
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NusA-NTD and NusA-AR2 share binding sites on λQ. In summary, λQ is able to establish interactions 
with NusA-NTD and NusA-AR2 and comparison of their binding sites on λQ suggests that they are partially 
overlapping, involving residues located in helices α3 and α5. To test if binding of NusA-NTD and NusA-AR2 
is indeed competitive, we carried out 2D [1H,15N]-HSQC-based competition experiments with spectra being 
recorded after each titration step. First, λQ was added in a two-fold molar excess to 15N-NusA-NTD, result-
ing in changes of the 15N-NusA-NTD spectrum typical for 15N-NusA-NTD:λQ complex formation (Fig. 3d and 
Supplementary Fig. 9a). Subsequent titration with NusA-AR2 reversed those changes partially (Fig. 3d), demon-
strating that NusA-AR2 complexes λQ, detaching it from NusA-NTD. To corroborate this finding we formed 
Figure 3. NusA interacts with λQ via its AR2 domain. (a) (top) Section of [1H,15N]-BEST-TROSY spectra 
of the titration of 250 µM 15N-λQ with NusA-AR2. NusA-AR2 (molar ratios: 1:0, black; 1:1, cyan; 1:2 red). 
Selected signals are labeled. (bottom) Relative intensity of 15N-λQ signals in the presence of two equivalents 
NusA-AR2. Error bars are given as black vertical lines. Orange and red lines indicate thresholds for moderately 
(1.0 σ of average relative signal intensity) and strongly (1.5 σ of average relative signal intensity) affected signals, 
respectively. The dashed line represents the mean relative intensity. (b) (top) Section of [1H,15N]-HSQC spectra 
of the titration of 250 µM 15N-NusA-AR2 with λQ (molar ratios: 1:0, black; 1:1, cyan; 1:2 red). Selected signals 
are labeled. (bottom) Normalized chemical shift changes of 15N-NusA-AR2 upon addition of two equivalents 
λQ. Yellow, orange, and red lines indicate thresholds for slightly (0.04 ppm ≤ Δδnorm < 0.08 ppm), moderately 
(0.08 ppm ≤ Δδnorm < 0.12 ppm) and strongly (Δδnorm ≥ 0.12 ppm) affected signals. (c) Model of the 
λQ:NusA-AR2 complex. The model was generated using the HADDOCK 2.2 server (https://haddock.science.
uu.nl/services/HADDOCK2.2/) with the affected residues as determined by NMR spectroscopy as restraints 
(see Supplementary Table 1). The model with the lowest HADDOCK score is depicted. λQ (PDB ID: 4MO1, 
lightblue) and NusA-AR2 (PDB ID: 1WCN, gray) are in ribbon representation. Affected residues are colored 
(λQ: moderately affected residues, orange; strongly affected residues, red; NusA-AR2: slightly affected residues, 
yellow; moderately affected residues, orange; strongly affected residues, red). Termini and secondary structure 
elements are labeled. Panels show the surface representations of λQ (left) and NusA-AR2 (right) colored as in 
the complex. The PyMOL Molecular Graphics System (Version 1.7, Schrödinger, LLC.; https://pymol.org) was 
used for visualization. (d) NusA-AR2 removes λQ from 15N-NusA-NTD. Sections of [1H,15N]-HSQC spectra 
are depicted. Molar ratios: 15N-NusA-NTD:λQ:NusA-AR2 = 1:0:0, black; =1:2:0, cyan; 1:2:2, orange; 1:2:4, red. 
Initial concentration of 15N-NusA-NTD: 250 µM. Selected signals are labeled, arrows indicate the chemical shift 
changes upon addition of λQ (cyan) and NusA-AR2 (red). (e) NusA-NTD detaches λQ from 15N-NusA-AR2. 
Sections of [1H,15N]-HSQC spectra are shown. Molar ratios: 15N-NusA-AR2:λQ:NusA-NTD = 1:0:0; black; 
=1:2:0; cyan; 1:2:2; orange; 1:2:4, purple; 1:2:6, yellow; 1:2:10, red. Initial concentration of 15N-NusA-AR2: 
250 µM. Selected signals are labeled, arrows show changes of chemical shifts upon addition of λQ (cyan) and 
NusA-NTD (red).
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a 15N-NusA-AR2:λQ complex (molar ratio 1:2) leading to chemical shift perturbations of the 15N-NusA-AR2 
signals that confirm λQ binding (Fig. 3e and Supplementary Fig. 9b). Upon addition of NusA-NTD the chem-
ical shifts shifted back towards their position in the spectrum of free 15N-NusA-AR2 (Fig. 3e), showing that 
NusA-NTD binds to λQ while removing it from NusA-AR2. Thus, the λQ:NusA-NTD and the λQ:NusA-AR2 
interactions are mutually exclusive with similar affinities.
λQ and RnApαCTD share binding sites on NusA-AR2. In free NusA the AR2 domain binds to the 
KH1 domain of the SKK motif, preventing RNA binding by NusA-SKK and rendering NusA autoinhibited39,41,42. 
This autoinhibition can be released by the αCTD of RNAP as NusA-SKK and αCTD share binding sites on 
NusA-AR239. NusA-AR2, however, can also bind to NusG-NTD, an interaction that might be involved in the 
regulation of Rho-dependent termination or in the recruitment of NusG40, and to SuhB17,18. The NusA-AR2:SuhB 
complex formation is suggested to play a role in the transcriptional or posttranscriptional regulation of ribosomal 
AT. Interestingly, the binding sites for NusG-NTD, SuhB, and αCTD as well as λQ on NusA-AR2 all involve the 
C-terminal helix α5 and overlap. Moreover, it has been demonstrated that the interactions of NusA-AR2 with 
NusG-NTD, αCTD, and SuhB are competitive18.
To show that also λQ competes with NusG-NTD, αCTD, and SuhB for NusA-AR2 binding we tested if the 
complexes λQ:NusA-AR2 and αCTD:NusA-AR2 are mutually exclusive by 2D NMR-based competition experi-
ments with spectra being recorded after each titration step. First, NusA-AR2 was added in a twofold molar excess 
to 15N-λQ, resulting in changes of the 15N-λQ spectrum corresponding to 15N-λQ:NusA-AR2 complex forma-
tion. Subsequent titration with the αCTD reversed both the chemical shift changes and the loss of signal intensity, 
showing that the αCTD detaches NusA-AR2 from λQ by binding to it (Fig. 4a and Supplementary Fig. 10a). 
To confirm this result we performed another competition experiment where λQ was titrated to a preformed 
15N-αCTD:NusA-AR2 complex (molar ratio 1:2). The addition of λQ reversed partially the chemical shift pertur-
bations caused by the 15N-αCTD:NusA-AR2 complex formation (Fig. 4b and Supplementary Fig. 10b), demon-
strating that λQ can bind to NusA-AR2 in order to remove it from the αCTD. Together with previous data18,40 
this finding leads to the conclusion that the NusA-AR2 binding sites for αCTD, λQ, NusG-NTD, and SuhB 
largely overlap, rendering the interactions of these binding partners with NusA-AR2 competitive. Finally, the KD 
value of the αCTD:NusA-AR2 interaction was determined by fluorescence anisotropy measurements using the 
NusA-AR2D443C variant to be 8±1 µM (Supplementary Fig. 10c), in agreement with a previous report39. Thus, the 
affinity of the NusA-AR2D443C:αCTD interaction is significantly higher than the one of the NusA-AR2D443C:λQ 
interaction, which explains why λQ is able to detach NusA-AR2 only partially from the αCTD (Fig. 4).
λQ may release the autoinhibition of nusA. NusA-AR2 binding sites for αCTD, NusG-NTD and SuhB 
not only overlap, but all these factors are able to remove NusA-AR2 from NusA-SKK, releasing autoinhibition 
of NusA18,39,41. Thus, we explored if λQ has the same ability employing NMR-based displacement experiments. 
Figure 4. αCTD and λQ share binding sites on NusA-AR2. NMR-based competition experiments of λQ, 
αCTD, and NusA-AR2. (a) NusA-AR2 is detached from 15N-λQ by αCTD. Sections of [1H,15N]-BEST-TROSY 
spectra are shown. Molar ratios: 15N-λQ:NusA-AR2:αCTD = 1:0:0, black; =1:2:0, cyan; 1:2:2, orange; 1:2:4, red. 
Initial concentration of 15N-λQ: 250 µM. Selected signals are labeled, arrows indicate chemical shift changes 
upon addition of NusA-AR2 (cyan) and αCTD (red). (b) λQ removes NusA-AR2 partially from 15N-αCTD. 
Sections of [1H,15N]-HSQC spectra are depicted. Molar ratios: Molar ratios: 15N-αCTD:NusA-AR2:λQ = 1:0:0; 
black; =1:2:0; cyan; 1:2:2; orange; 1:2:4, purple; 1:2:6, yellow; 1:2:10, red. Initial concentration of 15N-αCTD: 
250 µM. Selected signals are labeled and arrows show changes in chemical shifts upon addition of NusA-AR2 
(cyan) and λQ (red).
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In control experiments we titrated 2H,15N-labeled NusA-SKK with NusA-AR2 and vice versa and recorded 1D 
and 2D [1H,15N] correlation spectra after each titration step to determine the chemical shift perturbations caused 
by NusA-AR2:NusA-SKK complex formation on both sides (Fig. 5a,b and Supplementary Fig. 11a,b). For both 
titrations normalized chemical shift perturbations were plotted against the amino acid sequence of the labeled 
protein (Fig. 5a,b) and mapped on the 3D structures (Fig. 5c). The identified binding surfaces were in agreement 
with previous data39, i.e. the C-terminal part of NusA-AR2 is affected as well as the KH1 domain of NusA-SKK. 
Based on the normalized changes of the chemical shifts we estimated the affinity of the NusA-SKK:NusA-AR2 
interaction to be <341 µM (Supplementary Fig. 11c). In an alternative approach we determined the KD value by 
fluorescence anisotropy measurement employing the NusA-AR2D443C variant, yielding a slightly lower affinity 
(279 ± 17 µM; Supplementary Fig. 11d), similar to the one of the NusA-AR2D443C:λQ interaction. As no structure 
of autoinhibited NusA is available we performed NMR-guided docking using the results of the HSQC titrations 
Figure 5. λQ releases autoinhibition of NusA. (a) (top) Sections of [1H,15N]-BEST-TROSY spectra of the 
titration of 300 µM 2H,15N-NusA-SKK with NusA-AR2 (molar ratios: 1:0, black; 1:0.5, orange; 1:1, cyan; 1:2 
purple; 1:5 yellow; 1:7.5 red; stock concentration of NusA-AR2: 1.5 mM). Selected signals are labeled. (bottom) 
Normalized chemical shift perturbations of 2H,15N-NusA-SKK signals upon addition of 7.5 equivalents 
NusA-AR2. Yellow, orange, and red lines indicate thresholds for slightly (0.04 ppm ≤ Δδnorm < 0.08 ppm), 
moderately (0.08 ppm ≤ Δδnorm < 0.12 ppm) and strongly (Δδnorm ≥ 0.12 ppm) affected signals. (b) (top) 
Sections of [1H,15N]-HSQC spectra of the titration of 200 µM 15N-NusA-AR2 with NusA-SKK (molar ratios: 
1:0, black; 1:0.5, orange; 1:1, cyan; 1:2 purple; 1:5 yellow; 1:7.5 red; stock concentration of NusA-SKK: 500 µM). 
Selected signals are assigned. (bottom) Normalized chemical shift changes of 15N-NusA-AR2 upon addition of 
7.5 equivalents NusA-SKK. Thresholds as in (b). (c) Model of the NusA-SKK:NusA-AR2 complex. The model 
was generated with the HADDOCK 2.2 server (https://haddock.science.uu.nl/services/HADDOCK2.2/) 
using affected residues as determined by NMR spectroscopy as restraints (see Supplementary Table 1). The 
model with the lowest HADDOCK score and Z-score is depicted. NusA-AR2 (PDB ID: 1WCN, lightblue) and 
NusA-SKK (PDB ID: 5LM9, gray) are in ribbon representation. Affected residues are colored (slightly affected 
residues, yellow; moderately affected residues, orange; strongly affected residues, red). Termini and secondary 
structure elements are labeled. Panels show the surface representations of NusA-AR2 (left) and NusA-SKK 
(right), colored as in the complex, whereby the KH1 domain is highlighted in dark gray. The PyMOL Molecular 
Graphics System (Version 1.7, Schrödinger, LLC.; https://pymol.org) was used for visualization. (d) λQ and (e) 
λQΔ36 detach NusA-AR2 from 2H,15N-NusA-SKK. Sections of [1H,15N]-BEST-TROSY are shown. Molar ratios: 
2H,15N-NusA-SKK: NusA-AR2:λQ/λQΔ36 =1:0:0, black; =1:5:0, orange; =1:5:1, cyan; =1:5:2, purple; =1:5:5, 
yellow; =1:5:10, red. Initial concentration of 2H,15N-NusA-SKK: 175 µM. Selected signals are labeled and arrows 
indicate chemical shift changes upon addition of NusA-AR2 (cyan) and λQ/λQΔ36 (red).
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and without allowing for conformational changes to obtain a model of the NusA-SKK:NusA-AR2 complex 
(Fig. 5c). NusA-AR2 packs tightly against the KH1 domain via its C-terminal helix with an interaction surface of 
1230 Å2, blocking the RNA binding site. Addition of λQ to a preformed 2H,15N-NusA-SKK:NusA-AR2 complex 
(molar ratio 1:2) led to a partial reversal of all signal shifts (Fig. 5d and Supplementary Fig. 11e). This finding is in 
agreement with the KD values of the NusA-SKK:NusA-AR2 and NusA-AR2:λQ interactions and indicates that λQ 
binds to NusA-AR2 releasing NusA-SKK at the same time, thus being compatible with the release of NusA auto-
inhibition by λQ. However, one must bare in mind that isolated NusA domains were used in these experiments 
and that the affinity of NusA-AR2 for NusA-SKK might be higher in the full length protein due to an increased 
local concentration. Consequently, our results are in agreement with a λQ-induced release of autoinhibition of 
NusA, but not final prove. NMR-based approaches using the full length NusA protein failed due to stability issues. 
Repeating the competition experiment with λQΔ36 confirmed that the N-terminus is not required for this func-
tion of λQ (Fig. 5e and Supplementary Fig. 11f).
Discussion
Q-dependent AT is the second mechanism lambdoid phages use to suppress termination signals. N-mediated 
AT is the best studied AT mechanism by now whereas only little is known about AT relying on Q. Only recently, 
the structural basis for AT involving Q from bacteriophage 21 has been deciphered12,13. However, as mentioned 
before, Q proteins can be grouped into three families, Q21, Q82, and λQ, and these families show no significant 
amino acid sequence similarity and only very little similarity in the 3D structure (with structural information 
being available only for Q21 and a truncated version of λQ)12–14. Consequently, the molecular mechanisms they 
use to achieve AT might be completely different, despite the fact that all Q proteins seem to bind to or in the vicin-
ity of the βFTH in order to affect pausing and termination12,13,43,45. One striking difference between Q21 and λQ 
is for example that the latter has a long N-terminal region with unknown function that has been suggested to be 
unstructured. Moreover, two distinct activities have been suggested for Q82, namely antipausing and RNA occlu-
sion, which may both play a role in Q82 function43. Finally, it is known that Nus factors are involved in other AT 
mechanisms such as N-mediated and ribosomal AT6,7,15,17,18. At least NusA has been demonstrated to influence Q 
function in phages λ and 82, although the dependency of Q activity on NusA differs32,43,44,46. Thus, we set out to 
identify possible interactions of λQ with Nus factors.
Using solution-state NMR spectroscopy we assigned secondary structure elements of λQΔ36 and found that 
the solution structure is in good agreement with the crystal structure of an N-terminal truncation variant of 
λQ missing 38 amino acids (Fig. 1). Structural similarity to Q21 and region 4 of σ70 factor is limited to the 
helix-turn-helix (HTH) motif formed by helices α5 and α612,13,47,48, which might be involved in the recognition of 
the QBE14. Moreover, we confirmed that residues 1–66 are indeed unstructured (Fig. 1). It has been proposed that 
at least two molecules of λQ are involved in the AT process11 and NMR spectroscopy and analytical SEC indicate 
that λQ and λQΔ36 exist as monomers in solution, suggesting that the N-terminus does not induce oligomeriza-
tion. This implies several scenarios: (i) dimerization/oligomerization occurs upon DNA binding or loading to the 
paused TEC, similar to Q2112,13, (ii) several Q proteins are involved in AT, but do not interact with each other, or 
(iii) λQ acts as monomer that contacts both suggested binding sites in the QBE on the DNA11.
Q proteins bind to/near the βFTH of RNAP in order to exert their AT function12,13,45 and Q21 has been shown 
to form a nozzle at the RNA exit channel through which the nascent RNA is guided, preventing the formation 
of pause or termination hairpins12,13, i.e. AT can proceed without the need of any other factors. In contrast, Q82 
is supposed to form a shield for the exiting RNA in a NusA-dependent manner43 and also λQ-dependent AT is 
stimulated by NusA32,44,46. Thus, we asked if λQ makes direct interactions with any of the Nus factors and we show 
that λQ only interacts with NusA, contacting the NTD and the AR2 domain. In neither case the N-terminus 
of λQ is involved in the interaction so that its function remains elusive. Interestingly, the λQ binding sites for 
NusA-NTD and NusA-AR2 overlap so that NusA-NTD and NusA-AR2 binding are mutually exclusive (Fig. 6a,b), 
as confirmed by competition experiments, suggesting similar affinities and thus distinct roles for these complexes 
in λQ-dependent AT. Moreover, the NusA binding sites involve (at least partially) the HTH motif (Fig. 6c) so that 
NusA interaction might interfere with DNA binding and might thus be relevant only once λQ is loaded to the 
TEC, in agreement with the fact that NusA is usually recruited after the σ factor has left the TEC49. If more than 
one λQ molecule is loaded to the TEC, interactions with NusA-NTD, NusA-AR2 and DNA would be possible 
simultaneously.
The NusA-AR2:λQ interaction might have various regulatory roles. It could (i) stabilize the TAC, (ii) promote 
the engagement of λQ with the TAC, in agreement with a previous hypothesis32, (iii) mediate NusA loading if 
NusA enters the TAC after λQ, (iv) alter the RNA binding properties of NusA by releasing autoinhibition, or (v) 
recruit further λQ molecules in the course of transcription, which might be necessary as the late gene region in 
phage λ comprises 26 kb, (vi) a combination of several of these possible functions.
During transcriptional pausing NusA-NTD interacts with βFTH and the αCTD, the latter interaction involv-
ing NusA-NTD helices α3 and parts of the preceding loop2. Thus the NusA-NTD:αCTD binding site overlaps 
with the NusA-NTD:λQ interaction surface and both interactions are mutually exclusive as demonstrated by 
NMR-based competition experiments (Fig. 2d,e), but λQ does not directly bind to αCTD (Supplementary 
Fig. 6c). Interestingly, the absence of the αCTD affects the ability of NusA to stimulate λQ-dependent AT42, 
suggesting that the NusA-NTD:αCTD and NusA-NTD:λQ interactions have relevant roles in λQ-dependent AT.
NusA-NTD, λQ, and σ region 4 bind to the βFTH, competing for this binding site2,45,50. Thus, we hypothesize 
that upon loading λQ establishes contacts with the βFTH as σ region 4 has already been disengaged from its 
position in the initiation complex at this stage, as shown for Q2112,13. Our NMR data and a mutagenesis analy-
sis14 suggest that λQ, βFTH, and NusA-NTD cannot form a ternary complex as λQ binding sites for βFTH and 
NusA-NTD overlap, so that binding is competitive. In this case simultaneous contacts of λQ to the βFTH and 
NusA-NTD would only possible if more than one molecule λQ is present.
1 0Scientific RepoRtS |         (2020) 10:6607  | https://doi.org/10.1038/s41598-020-63523-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
Processive λN-mediated AT involves repositioning of NusA-NTD6,7 and a similar mechanism has been 
suggested for ribosomal AT17,18. Although the structures of TACs and antiterminators, the time of antitermi-
nator recruitment and the recruitment signals differ in Q-dependent, N-dependent, and ribosomal AT mecha-
nisms6,7,12,13,51 the repositioning of NusA-NTD might be a general scheme in AT. Thus, based on our findings we 
speculate that once recruited to the βFTH λQ may alter the usual NusA:RNAP and/or NusA:RNA contacts, which 
would finally result in a positioning of NusA-NTD in a way that may prevent the formation of pause and termina-
tion hairpins and thus enhances elongation, rendering Q-dependent AT, just like λN-dependent AT, processive6,7.
NusA is a central transcriptional regulator and well conserved in bacteria. It is a multidomain protein, but 
only NusA from E. coli and some other γ-proteobacteria contains the two AR domains at the C-terminus35. In 
its isolated form, NusA is autoinhibited as NusA-AR2 binds to the KH1 domain of the SKK motif39, preventing 
RNA binding by SKK (Fig. 6d). Regulation via autoinhibition is a common scheme in the regulation of all kinds 
of biochemical processes. In general, autoinhibition describes the negative regulation by intramolecular inter-
actions of different regions of the polypeptide chain, that may even be coupled to conformational changes, and 
that inhibit the function of at least one of the regions52,53. Only under certain circumstances, e.g. the binding of a 
specific effector, autoinhibition is released and the protein/enzyme is activated. On NusA-AR2 NusA-SKK bind-
ing involves the same region as the interaction with λQ (Figs. 3c and 5c), SuhB18, NusG-NTD40, and αCTD39. 
Moreover, all known interaction partners of NusA-AR2 are able to release the autoinhibition of NusA and may 
thus serve as NusA activators. This activation may occur in binary complexes or when NusA is bound to RNAP 
via NusA-NTD.
Figure 6. NusA functions during transcription regulation. (a-c) Interaction surfaces of λQ (λQ in surface 
representation, gray, PDB ID: 4MO1). Residues affected by NusA-NTD binding are colored in green (a; this 
study), NusA-AR2 binding in blue (b; this study), and βFTH and DNA binding in yellow and red, respectively 
(c; data taken from14). (d) Model of the autoinhibited state of NusA. NusA-AR2 (PDB ID: 1WCN, blue) is in 
ribbon, NusA-SKK (PDB ID: 5LM9, green) in surface representation, NusA-NTD and NusA-AR1 are depicted 
as green ellipsoids. The panel shows a magnification of the boxed region with W490 and F491 of NusA-AR2 
as red sticks. (e) Scheme of possible roles of NusA. NusA-AR2 is shown in ribbon representation (PDB ID: 
1WCN, blue) with W490 and F491 as red sticks, all other NusA domains and proteins are shown as ellipsoids 
and labeled. Selected RNAP binding sites are depicted in ribbon representation and labeled. Blue arrows 
indicate interactions of NusA-AR2 with other transcription factors, gray arrows show interactions with RNAP 
(the interaction of SuhB with RNAP requires further investigation and is displayed as dashed arrow). β’ clamp 
helices, β’CH. The PyMOL Molecular Graphics System (Version 1.7, Schrödinger, LLC.; https://pymol.org) was 
used for visualization of protein structures.
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NusA-AR1 and NusA-AR2 have nearly identical structures with 31.5% sequence identity and contain predom-
inantly acidic residues, resulting in a very similar electrostatic potential surface35. Nevertheless, each AR domain 
is able to recognize specific targets. NusA-AR1 specifically binds to antiterminator protein N from phage λ35,37, 
whereas several binding partners interact with NusA-AR2, e.g. λQ (Fig. 3), SuhB17,18, NusG-NTD40, and αCTD39. 
Interestingly, all these binding partners have overlapping binding sites on NusA-AR2, all involving helix α5, and 
all probably relying on a similar recognition mechanism based on the neighboring aromatic residues W490 and 
F491, located at the very C-terminus (Supplementary Fig. 12). A Leu (L414) and an Ala (A415) residue can be 
found at corresponding positions in NusA-AR1.
NusA is composed of several domains with the AR2 domain forming the C-terminus. As all domains are con-
nected via flexible linkers, NusA has a high intramolecular flexibility, i.e. even when NusA is bound to RNAP via 
its NTD and the SKK motif to RNA during transcription, the AR2 domains can still move virtually independently. 
Thus, the AR2 domain may serve as flexible and versatile recruitment platform that allows the specific recruit-
ment for various transcription factors in E. coli and other γ-proteobacteria (Fig. 6e), as suggested earlier18. Once 
bound to NusA-AR2 these regulators may stay at the AR2 domain or may be handed over to RNAP or other parts 
of the transcription machinery.
NusA has multiple, sometimes even opposing, functions, which are context- and regulator-dependent, rang-
ing from pause-stimulation to AT. NusA is recruited early in transcription elongation49 and its NTD occupies 
the same position as region 4 of the σ factor, i.e. it binds to the βFTH, which constitutes a part of the wall of the 
RNA exit channel2. By interacting with the βFTH NusA-NTD may affect the widening of the RNA exit channel, 
modulating the transcription speed2,6,7. Additionally, NusA-NTD is contacted by one of the αCTDs2, suggesting 
that NusA-NTD would still be tethered to RNAP even if the NusA-NTD:βFTH contact was lost (e.g. if a λQ pro-
tein is bound to the βFTH). As discussed above, the AR2 domain is able to establish highly specific contacts to 
other transcription factors, allowing their specific recruitment to the RNAP and thus facilitate the modulation of 
RNAP activity. Taken together, the early recruitment of NusA, its tuneable function and its ability for the specific 
recruitment of various other transcription regulators not only underline the central role of NusA in transcription 
regulation, but imply that NusA may be regarded as auxiliary/additional RNAP subunit, similar to the σ factor, 
although not being encoded in the rpo operon.
Methods
cloning and mutagenesis. The gene encoding λQ was amplified from the plasmid pUC57_lambdaq 
obtained from GenScript (Piscataway, NJ, USA; the gene was codon-optimized; additionally, an NcoI restric-
tion site was introduced permitting the generation of a λQ deletion variant lacking 36 amino acids at the 
N-terminus (see below) without changing the amino acid sequence) by polymerase chain reaction using the 
primers Q-PciI-FW (5′-gcacatgtcccgcctggaatccgtggcaaaatttcac-3′; PciI restriction site in bold) and Q-XhoI-RV 
(5′-gctcgagtcagcgggtaacggcattcagg -3′; XhoI restriction site in bold; both primers were obtained from Metabion, 
Martinsried, Germany) and cloned into the pETGB1a expression vector (provided by Gunter Stier, EMBL 
Heidelberg, Germany) via PciI and XhoI restriction sites, resulting in the recombinant plasmid pETGB1a_lamb-
daq. The gene coding for the Q variant lacking the 36 N-terminal residues, λQΔ36, was obtained by restriction of 
pUC57_lambdaq with NcoI and XhoI and cloned into pETGB1a (pETGB1a_lambdaqdNΔ36). Both recombinant 
target proteins have a hexa-histidine tag, the B1 domain of streptococcal protein G (GB1), and a Tobacco Etch 
Virus (TEV) cleavage site at their N-termini.
Gene expression and protein purification. Production of NusA was carried out as described40, as was 
production of NusA-NTD54, NusA-SKK55, NusA-AR137, NusA-AR240, NusA-AR2D443C 18, NusB28, NusEΔ:B28, 
NusG56, and αCTD35.
Expression of λq was carried out in E. coli Rosetta (DE3) plysSRARE (Novagen, Madison, USA) harboring 
the plasmid pETGB1a_lambdaq. Lysogeny broth (LB) medium (supplemented with 34 μg/ml chloramphenicol 
and 30 μg/ml kanamycin) was inoculated with an overnight preculture to an optical density at 600 nm (OD600) 
of 0.2 and incubated at 37 °C. When the culture reached an OD600 of 0.5 the temperature was decreased to 25 °C 
and overexpression was induced by addition of 0.2 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) at an 
OD600 of 0.7. Four hours after induction cells were harvested by centrifugation (6,000 × g, 10 min, 4 °C), resus-
pended in buffer Q-A (50 mM Tris(hydroxymethyl)aminomethane (Tris)/HCl, pH 7.4, 250 mM NaCl, 5 mM 
Dithiothreitol (DTT)), and lyzed using a microfluidizer (Microfluidics, Newton, USA). The lysate was cleared by 
centrifugation (75,000 × g, 30 min, 4 °C) and the crude extract was filtrated (0.45 µm filter) before being applied to 
a 5 ml HisTrap HP column (GE Healthcare, Chalfont St Giles, UK) loaded with Zn2+ instead of Ni2+-Ions. Upon 
washing with buffer Q-A elution was carried out via a step gradient with increasing imidazole concentrations 
(10 mM–500 mM in buffer Q-A). Fractions that contained His6-Gb1-λQ were combined and dialyzed against 
buffer Q-A (molecular weight cut-off (MWCO) 3,500 Da) at 4 °C overnight in the presence of TEV protease. The 
dialysate was loaded on a 5 ml HisTrap HP column (loaded with Zn2+) coupled to a 5 ml Heparin HP column (GE 
Healthcare, Munich, Germany) and the columns were washed with buffer Q-A. Subsequently, the HisTrap HP 
chelating column was removed and the Heparin HP column was eluted using a constant gradient from 250 mM 
to 1 M NaCl in buffer Q-A. Fractions that contained λQ protein were combined and dialyzed against buffer 
Q-B (50 mM 3-(N-morpholino)propanesulfonic acid (MOPS) buffer, pH 6.5, 300 mM NaCl, 150 mM D-Glucose, 
5 mM DTT; MWCO 3,500 Da) at 4 °C. The protein was polished by a gel filtration step using a Superdex75 10/600 
column (GE Healthcare, Munich, Germany) and buffer Q-B. Fractions containing pure λQ were concentrated by 
ultrafiltration (MWCO 3,000 Da), shock frozen in liquid nitrogen, and stored at −80 °C. The production of λQΔ36 
was carried out analogously.
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Analytical gel filtration of λQ and λQΔ36. Analytical gel filtration was carried out using a Superdex 75 
10/300 GL column (GE Healthcare, Munich, Germany; 20 mM Tris/HCl (pH 7.5), 150 mM NaCl, 5% (v/v) glyc-
erol). In order to estimate the molecular weights of λQ and λQΔ36 a standard curve was generated using aprotinin 
(6.5 kDa; Sigma-Aldrich, Darmstadt, Germany), ribonuclease (13.7 kDa; GE Healthcare, Munich, Germany), 
carbonic anhydrase (29.0 kDa; GE Healthcare, Munich, Germany), ovalbumin (43 kDa; GE Healthcare, Munich, 
Germany), and albumin (66.0 kDa; Sigma-Aldrich, Darmstadt, Germany). 250 µg protein were applied per run.
Quality control of recombinant proteins. The quality of proteins used in this study was assessed 
based on the guidelines established by ARBRE-MOBIEU and P4EU (https://arbre-mobieu.eu/guidelines-on- 
protein-quality-control/). Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
check the purity of proteins. UV/visible spectra from 220–340 nm were recorded on a Nanodrop ND-100 spec-
trometer (PEQLAB, Erlangen, Germany) to ensure the absence of nucleic acids and aggregation. In order to 
determine concentrations the absorbance at 280 nm was measured in a 10 mm quartz cuvette (Hellma, Müllheim, 
Germany) on a Biospectrometer basic (Eppendorf, Hamburg, Germany). Identity was confirmed by peptide mass 
fingerprinting (Department of Biochemistry, University of Bayreuth, Germany) and homogeneity was ensured 
by analytical gel filtration using a Superdex 75 or a Superdex 200 10/300 GL column (GE Healthcare, Munich, 
Germany). Circular dichroism (CD) spectroscopy (1 mm quartz cuvette; J-1100, JASCO, Pfungstadt, Germany) 
was performed to assess the folding state (the folding state of unlabeled λQ and λQΔ36 was additionally checked 
by recording one dimensional 1H-NMR spectra).
isotopic labeling of proteins. Isotopic labeling was essentially based on published protocols54. To pro-
duce uniformly 15N- or 15N,13C-labeled proteins E. coli cells were grown in minimal medium M957,58 containing 
(15NH4)2SO4 (CortecNet, Voisins-Le-Bretonneux, France) or (15NH4)2SO4 and 13C-glucose (Campro Scientific, 
Berlin, Germany) as sole source for nitrogen or carbon, respectively. For expression of λq and λqΔ36 Fe(III) citrate 
and the trace element solution were omitted, but ZnCl2 was added to a final concentration of 4 mg/ml. Deuterated 
proteins were produced by growing E. coli cells in M9 medium57,58 which was prepared with stepwise increasing 
amounts of D2O (25% (v/v), 50% (v/v), 99.9% (v/v) D2O; Eurisotop, Saint-Aubin, France). Expression and purifi-
cation protocols were the same as for proteins produced in LB medium.
nMR spectroscopy. NMR experiments were performed at 298 K on Bruker Avance 700 MHz, Bruker Ascend 
Aeon 900 MHz, and Bruker Ascend Aeon 1 000 MHz spectrometers, all being equipped with cryogenically cooled 
inverse triple resonance probes. The experimental setup and data analysis was done essentially as described18. 
Samples contained 10% (v/v) D2O for locking and were in 3 mm tubes with an initial volume of 250 µl, if not 
stated otherwise. In-house routines were used for data conversion and processing, MatLab (The MathWorks, Inc., 
Version 7.1.0.183) was used for visualization and analysis of one-dimensional (1D) spectra and NMRViewJ (One 
Moon Scientific, Inc., Westfield, NJ, USA) to visualize and analyze two-dimensional (2D) and three-dimensional 
(3D) spectra. Assignments for the backbone amide resonances of NusA-AR235, NusA-AR159, NusA-SKK39, 
αCTD39, and NusA-NTD54 were taken from previous studies.
For resonance assignment of the λQΔ36 backbone BEST-TROSY-based triple resonance experiments60–62 
were recorded using 5 mm tubes (500 µl sample volume) with the 2H,13C,15N-labeled protein (270 µM) being in 
25 mM MES (pH 7.0), 100 mM NaCl, 5 mM DTT. 15N-longitudinal and transverse relaxation rates of λQΔ36 were 
recorded with a 15N-labeled sample at 298 K and 700.2 MHz 1H frequency using standard methods63. Relaxation 
delays were fitted to a monoexponential decay by NMRViewJ (One Moon Scientific, Inc., Westfield, NJ, USA). 
The rotation correlation time was determined using the TENSOR 2 package64 assuming an isotropic model for 
molecular tumbling. Only residues located in rigid regions were used in the analysis. The error of R1 and R2 was 
set to 5% and 8%, respectively, according to ref. 65.
For interaction studies and competition experiments proteins were in 50 mM MOPS, pH 6.5, 300 mM NaCl, 
150 mM D-Glucose, 5 mM DTT (exception: 5 mm tubes were used to study the interaction of NusA-SKK with 
NusA-AR2 with proteins being in 50 mM MOPS, pH 6.5, 100 mM NaCl, 150 mM D-Glucose, 5 mM DTT). Either 
[1H,15N]-HSQC or [1H,15N]-BEST-TROSY experiments were used to record [1H,15N] correlation spectra. To 
compare 1D spectra we normalized them by receiver gain, length of the 90° proton pulse, number of scans, and 
protein concentration.
[1H,15N] correlation-based titrations (either HSQC or BEST-TROSY) were analyzed quantitatively by calcu-
lating either changes in intensity or changes in chemical shifts. If chemical shift changes were in the fast regime 
of chemical exchange we calculated the normalized chemical shift perturbation (Δδnorm) according to Eq. (1).
δ δ δΔ = Δ + . ⋅ ΔH N( ) [0 1 ( )] (1)norm
1 2 15 2
with Δδ being the resonance frequency difference in ppm.
Plotting of Δδnorm against the amino acid position of the labeled protein and introduction of thresholds at 0.04 
ppm, 0.08 ppm, and 0.12 ppm allowed the identification of slightly, moderately, and strongly affected residues. In 
order to determine dissociation constants (KD) from these titrations we analyzed the normalized chemical shift 
changes (in Hz) and fitted a two-state model (Eq. 2) to the chemical shift change of amide protons showing fast 
exchange in the chemical shift timescale.
Δν Δν= ⋅
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with Δν being the normalized resonance frequency difference (Hz), ΔνEnd the normalized resonance frequency 
difference between free and fully bound protein (Hz), r the ratio of unlabeled to labeled protein, and [P]0 the 
total concentration of 15N-labeled protein (the decrease of [P]0 due to dilution was taken into account during 
fitting). Fitting was done using MatLab (The MathWorks, Inc., Version 7.1.0.183) with KD and ΔνEnd being fitting 
parameters.
If the system was in slow or intermediate chemical exchange the signal intensities were analyzed quantitatively 
as described66. In brief, signal intensities were normalized by receiver gain, length of the 90° proton pulse, number 
of scans, and protein concentration. In order to eliminate an intensity decrease due to slight precipitation signals 
within one spectrum were normalized to the most intense signal. Subsequently, we calculated the relative signal 
intensity in each titration step, i.e. the ratio of the remaining, normalized signal intensity of the spectrum of the 
respective titration step to the normalized signal intensity of the spectrum of the free, labeled protein. The error 
was calculated based on the standard deviation of the noise level applying error propagation. Then, we calculated 
the mean value of all relative signal intensities in each titration step and residues with relative signal intensities 
below thresholds at 1 and 1.5 σ of the mean value were classified as moderately or strongly affected, respectively.
fluorescence anisotropy measurements. Fluorescence anisotropy measurements were per-
formed as described18. Site-specific labeling of NusA-AR2D443C with fluorescein-5-maleimide (ThermoFisher 
Scientific, Waltham, USA) was done according to the manufacturer’s protocol, i.e. after incubation of 25 µM 
of NusA-AR2D443C with 750 µM fluorescein-5-maleimide in labeling buffer (20 mM Na phosphate, pH 7.0, 
150 mM NaCl) at 4 °C overnight the solution was loaded on a PD MiniTrap Sephadex G-25 gravity column 
(GE Healthcare, Munich, Germany) equilibrated with fluorescence buffer (50 mM Na-P, pH 6.5, 100 mM NaCl, 
150 mM glucose, 5 mM DTT, 0.05% (v/v) Tween). Elution was carried out with fluorescence buffer. The protein 
concentration and the degree of labeling were determined by UV/vis spectroscopy on a Nanodrop ND-1000 
spectrometer (PEQLAB, Erlangen, Germany) according to the manufacturer’s protocol.
For each titration step individual 100 µl samples were prepared with each sample containing 25 nM labeled 
NusA-AR2D443C and increasing concentrations of unlabeled protein. All proteins were in fluorescence buffer and 
measurements were done in black, sterile 96-well microtiter plates (Brand, Wertheim, Germany) at 25 °C in a 
Synergy 2 microplate reader (BioTek, Winooski, USA). Four independent replicates were prepared per titration 
step and the anisotropy values were averaged. Finally, the mean anisotropy values were plotted against the titrant 
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where A is the measured anisotropy, AS the anisotropy of labeled NusA-AR2D443C, Acomplex the anisotropy 
of the complex, [complex] the concentration of the complex, [S]0 and [P]0 the total concentrations of labeled 
NusA-AR2D443C and the titrant, respectively, KD the dissociation constant, and R the ratio of the fluorescence 
intensities of fully bound and free substrate at 520 nm.
Docking. The complexes λQ:NusA-NTD, λQ:NusA-AR2, and NusA-AR2:NusA-SKK were modeled with the 
HADDOCK 2.2 server (https://haddock.science.uu.nl/services/HADDOCK2.2/)67 using H-N correlation data 
from NMR titrations as restraints (Supplementary Table 1). The size of interaction interfaces was calculated via 
the “Protein interfaces, surfaces and assemblies” service PISA at the European Bioinformatics Institute (http://
www.ebi.ac.uk/pdbe/prot_int/pstart.html68.
Visualization of protein structures. The PyMOL Molecular Graphics System (Version 1.7, Schrödinger, 
LLC.; https://pymol.org) was used for graphical representations of protein structures.
Data Availability
The chemical shift assignment of λQΔ36 were deposited in the Biological Magnetic Resonance Data Bank 
under the accession code 28043. We generated models of the λQ:NusA-NTD, the λQ:NusA-AR2, and the 
NusA-SKK:NusA-AR2 complex. Coordinates for λQ, NusA-NTD, NusA-SKK, and NusA-AR2 are available in 
the Protein Data Bank (PDB; 4MO1, 2KWP, 5LM9, 1WCN), the coordinates of the best complex models are 
provided as Supplementary data. Other data and materials are available from the corresponding author upon 
reasonable request.
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